References
- Greaves M. W., Weinstein G. D. Treatment of psoriasis. N. Engl. J. Med. 1995; 332(9)581–588
- van de Kerkhof P. C., Vissers W. H. The topical treatment of psoriasis. Skin Pharmacol. Appl. Skin Physiol. 2003; 16(2)69–83
- Cunliffe W. J., Berth‐Jones J., Claudy A., Fairiss G., Goldin D., Gratton D., Henderson C. A., Holden C. A., Maddin W. S., Ortonne J. P. Comparative study of calcipotriol (MC 903) ointment and betamethasone 17‐valerate ointment in patients with psoriasis vulgaris. J. Am. Acad. Dermatol. 1992; 26(5)736–743
- Kragballe K., Gjertsen B. T., De Hoop D., Karlsmark T., van de Kerkhof P. C., Larko O., Nieboer C., Roed‐Petersen J., Strand A., Tikjob G. Double‐blind, right/left comparison of calcipotriol and betamethasone valerate in treatment of psoriasis vulgaris. Lancet 1991; 337(8735)193–196
- Kragballe K., Barnes L., Hamberg K. J., Hutchinson P., Murphy F., Moller S., Ruzicka T., van de Kerkhof P. C. Calcipotriol cream with or without concurrent topical corticosteroid in psoriasis: tolerability and efficacy. Br. J. Dermatol. 1998; 139(4)649–654
- Lebwohl M., Siskin S., Epinette W., Breneman D., Funicella T., Kalb R., Moore J. A multicenter trial of calcipotriene ointment and halobetasol ointment compared with either agent alone for the treatment of psoriasis. J. Am. Acad. Dermatol. 1996; 35(2)268–269
- Ruzicka T., Lorenz B. Comparison of calcipotriol monotherapy and a combination of calcipotriol and betamethasone valerate after 2 weeks' treatment with calcipotriol in the topical therapy of psoriasis vulgaris: a multicentre, double‐blind, randomized study. Br. J. Dermatol. 1998; 138(2)254–258
- Lebwohl M. Topical application of calcipotriene and corticosteroids: combination regimens. J. Am. Acad. Dermatol. 1997; 37(3)S55–S58
- Didriksen E., Høy G. Pharmaceutical Composition. January 27, 2000, International patent application no. WO 00/64450
- Patel B., Siskin S., Krazmien R., Lebwohl M. Compatibility of calcipotriene with other topical medications. J. Am. Acad. Dermatol. 1998; 38(6)1010–1011
- Loftsson T., Petersen D. S. Cyclodextrin solubilization of water‐insoluble drugs: Calcipotriol and EB‐1089. Pharmazie 1997; 52(10)783–785
- Traulsen J., Hughes‐Formella B. J. The atrophogenic potential and dermal tolerance of calcipotriol/betamethasone dipropionate ointment compared with betamethasone dipropionate ointment. Dermatology 2003; 207(2)166–172
- Franz T. J. Percutaneous absorption. on the relevance of in vitro data. J. Invest. Dermatol. 1975; 64(3)190–195
- Skelly J. P., Shah V. P., Maibach H., Guy R. H., Wester R. C., Flynn G. L., Yacobi A. FDA and AAPS report on the workshop on principles and practices of in vitro percutaneous penetration studies: relevance to bioavailability and bioequivalence. Pharm. Res. 1987; 4(3)265–267
- Dick I. P., Scott R. C. Pig ear skin as an in‐vitro model for human skin permeability. J. Pharm. Pharmacol. 1992; 44(8)640–645
- Douglas W. S., Poulin Y., Decroix J., Ortonne J. P., Mrowietz U., Gulliver W., Krogstad A. L., Larsen F. G., Iglesias L., Buckley C., Bibby A. J. A new calcipotriol/betamethasone formulation with rapid onset of action was superior to monotherapy with betamethasone dipropionate or calcipotriol in psoriasis vulgaris. Acta Derm.‐Venereol. 2002; 82(2)131–135
- Guenther L., van de Kerkhof P. C., Snellman E., Kragballe K., Chu A. C., Tegner E., Garcia‐Diez A., Springborg J. Efficacy and safety of a new combination of calcipotriol and betamethasone dipropionate (once or twice daily) compared to calcipotriol (twice daily) in the treatment of psoriasis vulgaris: a randomized, double‐blind, vehicle‐controlled clinical trial. Br. J. Dermatol. 2002; 147(2)316–323
- Papp K. A., Guenther L., Boyden B., Larsen F. G., Harvima R. J., Guilhou J. J., Kaufmann R., Rogers S., van de Kerkhof P. C., Hanssen L. I., Tegner E., Burg G., Talbot D., Chu A. C. Early onset of action and efficacy of a combination of calcipotriene and betamethasone dipropionate in the treatment of psoriasis. J. Am. Acad. Dermatol. 2003; 48(1)48–54
- Kaufmann R., Bibby A. J., Bissonnette R., Cambazard F., Chu A. C., Decroix J., Douglas W. S., Lowson D., Mascaro J. M., Murphy G. M., Stymne B. A new calcipotriol/betamethasone dipropionate formulation (daivobet) is an effective once‐daily treatment for psoriasis vulgaris. Dermatology 2002; 205(4)389–393